Subsequent qPCR and IHC findings confirmed that SCNN1A and EFNA1 were highly expressed in both in situ carcinoma and OV-derived exosomes, supporting their potential as reliable biomarkers for OV. The gene discussed is SCNN1A; the disease is in situ carcinoma.